Medicines Substances Companies Statistics

A free, open platform for EU medicines data, based on official EMA data.

Database

Medicines
Substances
Companies

Data Sources

EMA

2026 uMedical - Open Source Project

Imprint
Privacy Policy
Terms
Contact

Bamlanivimab and etesevimab for COVID-19

Withdrawn from rolling reviewHuman

Details

EMA number	EMEA/H/C/005836
ATC code	-
Authorisation	-
Revision	-

Therapeutic indication

Not specified

Active substances

bamlanivimab Etesevimab

Marketing Authorisation Holder

Eli Lilly Nederland B.V.

Bamlanivimab and etesevimab for COVID-19 | uMedical